MDxHealth S.A.
MDXH
Rank in Stocks
#21535
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Share Price
$3.58
Last synced: 2023-12-15
Market Cap
$101.57M
Change (1 day)
3.79%
Change (1 year)
0.01%
Country
BE
Trade MDxHealth S.A. (MDXH)
Category
Healthcare
Market Capitalization of MDxHealth S.A.(MDXH)
Market Cap: $101.57M
As of October 2026 MDxHealth S.A. has a market cap of $101.57M. This makes MDxHealth S.A. the world's 21535th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of MDxHealth S.A. from 2008 to 2026
MDXH compared with Top 5 Most Popular stocks
